+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veloxis Pharmaceuticals A/S - logo

Veloxis Pharmaceuticals is a commercial-stage specialty pharmaceutical company that operates in Europe and the United States. Veloxis’ products include tacrolimus extended-release tablets called Envarsus XR and MeltDose, which is designed to enhance the absorption and bioavailability of select orally administered drugs. The company was formerly known as LifeCycle Pharma A/S and changed its name to Veloxis Pharmaceuticals A/S in July 2011. Veloxis is based in Copenhagen, Denmark.

Transplant Rejection Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Transplant Rejection Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • August 2018
  • 1938 Pages
From
From
From
From
From
From
From
Veloxis Pharmaceuticals A/S - Product Thumbnail Image

Veloxis Pharmaceuticals A/S

  • Company Profile
  • January 2020
  • 75 Pages
Loading Indicator
adroll